INTRODUCTION TO CLINICAL INVESTIGATION Interface with Biomedical Industry

1 / 21
About This Presentation
Title:

INTRODUCTION TO CLINICAL INVESTIGATION Interface with Biomedical Industry

Description:

INTRODUCTION TO CLINICAL INVESTIGATION. Interface with Biomedical Industry. Mary Lee Vance, M.D. ... CLINICAL RESEARCH. Requirements. All clinical studies: ... – PowerPoint PPT presentation

Number of Views:30
Avg rating:3.0/5.0
Slides: 22
Provided by: cjwoo

less

Transcript and Presenter's Notes

Title: INTRODUCTION TO CLINICAL INVESTIGATION Interface with Biomedical Industry


1
INTRODUCTION TO CLINICAL INVESTIGATION Interface
with Biomedical Industry
  • Mary Lee Vance, M.D.
  • Professor of Medicine and Neurosurgery
  • Department of Medicine
  • Endocrinology and Metabolism

2
CLINICAL RESEARCHTypes of Studies
  • Investigator initiated proposal submitted to
    industry sponsor - request drug, financial
    support or both
  • Sponsor initiated usually a multicenter clinical
    trial sponsor provides protocol, budget (must be
    negotiated)

3
CLINICAL RESEARCHRequirements
  • All clinical studies must be approved by Human
    Investigation Committee (IRB) protocol
    consent form
  • General Clinical Research Center must be
    approved by GCRC Advisory Committee (reviewed
    before IRB review)

4
CLINICAL RESEARCHRequirements
  • Sponsor initiated study
  • IRB fee to review (1,250)
  • GCRC use inpatient outpatient sponsor assumes
    all costs

5
CLINICAL RESEARCHRequirements
  • Investigator initiated study
  • No IRB fee to review protocol
  • GCRC use no charge for use of inpatient or
    outpatient facility (some lab charges may be
    covered, depending on cost need to consult with
    GCRC administrator)

6
CLINICAL RESEARCHRequirements
  • Cannot charge patients for any cost of industry
    sponsored studies
  • ? Current policy on conducting studies in
    outpatient clinic setting

7
CLINICAL RESEARCHIndustry Support
  • How to participate in a clinical trial?
  • Need a contact ask your colleagues contact
    research director of a company that is involved
    with your field.
  • Ask your rep if he/she knows of any planned
    studies (usually not helpful, but worth a try)

8
CLINICAL RESEARCHMulticenter Clinical Trial
  • Items to consider BEFORE participation
  • Is the study scientifically valid?
  • Does it have potential for publication?
  • Is the budget adequate? (you dont work for the
    pharmaceutical company)
  • Do you have the resources/time to participate?
  • Do you have patients you can enroll?

9
CLINICAL RESEARCHMulticenter Clinical Trial
  • You decide to participate Contract
  • Have the contract reviewed by Deans office
    before writing the protocol consent form
  • U Va has specific requirements will resolve
    contract issues directly with the sponsor (Betty
    Pincus is terrific)

10
CLINICAL RESEARCHMulticenter Clinical Trial
  • You decide to participate budget negotiations
  • The sponsors budget is usually inadequate
  • University overhead 25 ? Department overhead
    (10 for Dept. Medicine)
  • Protocol preparation IRB review fees
  • Travel, lodging, parking costs for patients
  • Professional supervision (your salary support)

11
CLINICAL RESEARCHMulticenter Clinical Trial
  • You decide to participate budget negotiations
  • Patient payment necessary if patient does not
    benefit from study (e.g. dose finding study or
    pharmacokinetic study)
  • Normal volunteer study must pay for
    participation
  • Include secretarial, mail, fax, telephone,
    publication costs

12
CLINICAL RESEARCHMulticenter Clinical Trial
  • You decide to participate budget negotiations
  • Laboratory check on discount rate
  • Radiology check on discount rate
  • ECG check on discount rate
  • Will need to set up special billing for these
    charges billed directly to your grant account

13
CLINICAL RESEARCHMulticenter Clinical Trial
  • Publication
  • Authorship, order of authorship, control over
    final manuscript
  • Should be stated in the contract

14
CLINICAL RESEARCHMulticenter Clinical Trial
  • Investigator Meeting
  • Required by FDA
  • 1-2 day session review of protocol,
    requirements, discussion
  • Study coordinator also attends (CRF training)

15
CLINICAL RESEARCHMulticenter Clinical Trial
  • Case Report Forms (CRF)
  • Sponsor sends monitor before, during at
    completion of study to review records, queries
  • This takes more time than you think consider
    adding line item in budget to cover your time
    coordinators time

16
CLINICAL RESEARCHMulticenter Clinical Trial
  • Laboratory certification
  • Sponsor requires documentation of certification
    for Clinical Laboratory (not a problem at U Va)
    obtain certificate from Clinical Pathology

17
CLINICAL RESEARCHMulticenter Clinical Trial
  • Study Coodinator
  • Full time expensive, not always practical for a
    new investigator
  • Do you have the time to attend to details,
    paperwork?

18
CLINICAL RESEARCHRewards
  • Cutting edge research new treatments examples
    FDA approval
  • GHRH physiology treatment GH deficiency
  • 3 dopamine agonists for prolactin producing
    pituitary tumors
  • 2 somatostatin analogs for acromegaly
  • GH receptor antagonist for acromegaly
  • GH replacement in adults depot GH
  • Transdermal testosterone, 2 drugs

19
CLINICAL RESEARCHSummary
  • Advances clinical science (human beings the
    ultimate in translational research)
  • Potential for new medical treatments, procedures
  • Requires a great deal of paperwork, but worth it!

20
EFFECT OF OCTREOTIDE OR SOMAVERT
2100
Somavert (10 - 35 mg/day)
1800
Octreotide Bromocriptine
1500
1200
IGF-I (ng/ml)
900
Gamma Knife
TSS
600
Radiosurgery
Normal Range
300
0
Jul-93
Jul-94
Jul-95
Jul-96
Jul-97
Jul-98
Jul-99
Jan-94
Jan-95
Jan-96
Jan-97
Jan-98
Jan-99
Jan-00
Time
GDM
21
Sugar My New Bulldog
Write a Comment
User Comments (0)